FDA Reviewing Safety Of Popular Weight-Loss Drug
The U.S. Food and Drug Administration has launched a safety review into versions of the popular weight-loss drug orlistat marketed by Roche Applied Science and GlaxoSmithKline after receiving adverse event reports....To view the full article, register now.
Already a subscriber? Click here to view full article